Table 2.
Baseline participants’ demographics and medical data in each group
| Total sample (N = 95) | Intervention group (N = 48) | WLCG (N = 47) | |
|---|---|---|---|
| Demographics | |||
| Age (years) | |||
| Mean (SD) | 53.85 (11.91) | 51.65 (12.54) | 56.11 (10.90) |
| Range | 24–78 | 24–78 | 30–78 |
| Gender, N (%) | |||
| Women | 95 (100) | 48 (100) | 47 (100) |
| Marital status, N (%) | |||
| Single | 6 (6.32) | 3 (6.25) | 3 (6.38) |
| Married/living with partner | 63 (66.32) | 35 (72.92) | 28 (59.57) |
| Divorced/separated/widowed | 15 (15.79) | 5 (10.42) | 10 (21.28) |
| In a relationship but not living together | 11 (11.58) | 5 (10.42) | 6 (12.77) |
| Cultural origin, N (%) | |||
| Western Europe | 92 (96.84) | 45 (93.75) | 47 (100) |
| Eastern Europe | 3 (3.16) | 3 (6.25) | 0 (0.00) |
| Education level, N (%) | |||
| Elementary school or less | 1 (1.05) | 0 (0.00) | 1 (2.13) |
| Lower secondary school | 8 (8.42) | 3 (6.25) | 5 (10.64) |
| Upper secondary school | 25 (26.32) | 14 (29.17) | 11 (23.40) |
| Bachelor’s degree | 38 (40.00) | 19 (39.58) | 19 (40.43) |
| Master’s degree | 20 (21.05) | 11 (22.92) | 9 (19.15) |
| Post-graduate | 3 (3.16) | 1 (2.08) | 2 (4.26) |
| Employment status, N (%) | |||
| Employed full time | 7 (7.37) | 4 (8.33) | 3 (6.38) |
| Employed part time | 21 (22.11) | 9 (18.75) | 12 (25.53) |
| Incapacity of work/invalidity | 37 (38.95) | 22 (45.83) | 15 (31.91) |
| Unemployed/student/housewife/house-husband/retired/other | 30 (31.58) | 13 (27.08) | 17 (36.17) |
| Children, N (%) | |||
| Yes | 82 (86.32) | 40 (83.33) | 42 (89.36) |
| No | 13 (13.68) | 8 (16.67) | 5 (10.64) |
| Patient medical history | |||
| Cancer diagnosis, N (%) | |||
| Breast cancer | 75 (78.94) | 38 (79.17) | 37 (78.72) |
| Others | 20 (21.06) | 10 (20.83) | 10 (21.28) |
| Digestive (stomach, peritoneum, pancreas) | 5 (5.26) | 3 (6.25) | 2 (4.26) |
| Hematological cancer (lymphoma, leukemia) | 4 (4.22) | 3 (6.25) | 1 (2.13) |
| Gynecological cancer (cervix, ovaries) | 4 (4.22) | 3 (6.25) | 1 (2.13) |
| Skin | 2 (2.11) | 0 (0.00) | 2 (4.26) |
| Thyroid | 2 (2.11) | 0 (0.00) | 2 (4.26) |
| Ear/nose/throat | 1 (1.05) | 0 (0.00) | 1 (2.13) |
| Lung | 1 (1.05) | 1 (2.08) | 0 (0.00) |
| Brain | 1 (1.05) | 0 (0.00) | 1 (2.13) |
| Time since diagnosis (months) | |||
| Mean (SD) | 10.65 (8.69) | 9.94 (5.13) | 11.38 (11.25) |
| Range | 1–72 | 2–24 | 1–72 |
| Surgery, N (%) | |||
| Yes | 92 (96.84) | 46 (95.83) | 46 (97.87) |
| No | 3 (3.16) | 2 (4.17) | 1 (2.13) |
| Chemotherapy (CT), N (%) | |||
| Yes | 52 (54.74) | 29 (60.42) | 23 (48.94) |
| No | 43 (45.26) | 19 (39.58) | 24 (51.06) |
| Radiation therapy (RT), N (%) | |||
| Yes | 70 (73.68) | 35 (72.92) | 35 (74.47) |
| No | 25 (26.32) | 13 (27.08) | 12 (25.53) |
| Hormonal therapy (HT), N (%) | |||
| Yes | 60 (63.16) | 30 (62.50) | 30 (63.83) |
| No | 35 (36.84) | 18 (37.50) | 17 (36.17) |
| Other treatment, N (%) | |||
| Yes | 15 (15.79) | 9 (18.75) | 6 (12.77) |
| No | 80 (84.21) | 39 (81.25) | 41 (87.23) |
| History of cancer, N (%) | |||
| Yes | 18 (18.95) | 8 (16.67) | 10 (21.28) |
| No | 77 (81.05) | 40 (83.33) | 37 (78.72) |
| Other chronic health problem, N (%) | |||
| Yes | 55 (57.89) | 27 (56.25) | 28 (59.57) |
| No | 40 (42.11) | 21 (43.75) | 19 (40.43) |
| Consumption of psychotropic during the study, N (%) | |||
| Yes | 50 (52.63) | 27 (56.25) | 23 (48.94) |
| No | 45 (47.37) | 21 (43.75) | 24 (51.06) |